Back to results

CompletedPhase 2

A Safety and Tolerability Evaluation of Two 10-Week Dose Regimens of Orally-Administered PF-04494700 in Alzheimer's Patients

NCT00141661

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Pfizer Investigational Site

Sun City, Arizona, United States

+11 additional locations

View on ClinicalTrials.gov

Save this trial

Quick facts

Start date: 2005-10
Enrollment: 67 participants
Sponsor: Pfizer
Purpose: treatment

Locations (12)

Pfizer Investigational SiteSun City, Arizona, United States
Pfizer Investigational SiteFresno, California, United States
Pfizer Investigational SiteSan Diego, California, United States
Pfizer Investigational SiteSan Francisco, California, United States
Pfizer Investigational SiteFort Lauderdale, Florida, United States
Pfizer Investigational SiteFort Myers, Florida, United States
Pfizer Investigational SiteHallandale, Florida, United States
Pfizer Investigational SiteJacksonville, Florida, United States
Pfizer Investigational SiteLargo, Florida, United States
Pfizer Investigational SiteOrlando, Florida, United States
Pfizer Investigational SiteWest Palm Beach, Florida, United States
Pfizer Investigational SiteMemphis, Tennessee, United States

A Safety and Tolerability Evaluation of Two 10-Week Dose Regimens of Orally-Administered PF-04494700 in Alzheimer's Patients — TrialFind